LISATA THERAPEUTICS, INC. (LSTA)
About LISATA THERAPEUTICS, INC.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $170.0K
- Net income
- -$16.6M
- Total assets
- $17.7M
- Market cap
- $30.5M
- Operating margin
- -10711.2%
- Net margin
- -9756.5%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $170.0K
- Operating expenses
- $18.4M
- Operating income
- -$18.2M
- Income tax
- -$962.0K
- Net income
- -$16.6M
- EPS (basic)
- $-1.91
- EPS (diluted)
- $-1.91
Balance sheet
- Total assets
- $17.7M
- Current assets
- $17.7M
- Total liabilities
- $3.1M
- Current liabilities
- $3.1M
- Shareholders’ equity
- $14.6M
Cash flow
- Operating cash flow
- -$15.9M
- Investing cash flow
- $15.1M
- Financing cash flow
- $599.0K
- Net cash flow
- -$253.0K
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $30.5M
- EPS (diluted)
- $-1.91
- Shares outstanding
- 18.3M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Mar 1, 1999
Lisata Therapeutics, Inc. (LSTA) Stock Price
- Reported a net loss of $16.6M in FY2025.
- Trading 67% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review LISATA THERAPEUTICS, INC..
Write a review
News about LISATA THERAPEUTICS, INC.
News & sentiment via Polygon.io
Lisata Therapeutics, Inc.: frequently asked questions
Is Lisata Therapeutics, Inc. an American company?
Lisata Therapeutics, Inc. is a US-based company headquartered in Basking Ridge, New Jersey, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Lisata Therapeutics, Inc. headquartered?
Lisata Therapeutics, Inc. is headquartered in Basking Ridge, New Jersey, United States.
Is Lisata Therapeutics, Inc. publicly traded?
Yes — Lisata Therapeutics, Inc. is a publicly traded company. Its stock trades under the ticker symbol LSTA on the NASDAQ.
What does Lisata Therapeutics, Inc. do?
Lisata Therapeutics, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
